Dolastatin 15 derivatives

Details Dolastatin 15 derivatives Dolastatin 15 derivatives

2006-04-18

2010-02-16

Marschel, Ardin (Department: 1614)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S002600, C514S016700, C530S328000, C530S329000, C530S330000

Reexamination Certificate

active

07662786

ABSTRACT:
Compounds of the present invention include cell growth inhibitors which are peptides of Formula I,in-line-formulae description="In-line Formulae" end="lead"?A-B-D-E-F-(G)r-(K)s-L   (I),in-line-formulae description="In-line Formulae" end="tail"?and acid salts thereof, wherein A, B, D, E, F, G and K are α-amino acid residues, and s and r are each, independently, 0 or 1. L is a monovalent radical, such as, for example, an amino group, an N-substituted amino group, a β-hydroxylamino group, a hydrazido group, an alkoxy group, a thioalkoxy group, an aminoxy group, or an oximato group. The present invention also includes a method for treating cancer in a mammal, such as a human, comprising administering to the mammal an effective amount of a compound of Formula I in a pharmaceutically acceptable composition.

REFERENCES:
patent: 4816444 (1989-03-01), Pettit et al.
patent: 5448045 (1995-09-01), Clark
patent: 5502032 (1996-03-01), Haupt et al.
patent: 5504191 (1996-04-01), Pettit et al.
patent: 5530097 (1996-06-01), Pettit et al.
patent: 5554725 (1996-09-01), Pettit
patent: 5554993 (1996-09-01), Brickell
patent: 5618232 (1997-04-01), Martin
patent: 5807984 (1998-09-01), Kling et al.
patent: 5831002 (1998-11-01), Haupt et al.
patent: 5970143 (1999-10-01), Schneier et al.
patent: 6104815 (2000-08-01), Alcorn et al.
patent: 6143721 (2000-11-01), Janssen et al.
patent: 6438382 (2002-08-01), Boesch et al.
patent: 6458765 (2002-10-01), Janssen et al.
patent: 6554705 (2003-04-01), Cumbers
patent: 6629591 (2003-10-01), Griswold et al.
patent: 7084110 (2006-08-01), Janssen et al.
patent: 0398558 (1990-11-01), None
patent: 0598129 (1994-05-01), None
patent: WO-93/23424 (1993-11-01), None
patent: WO-96/18408 (1996-06-01), None
patent: WO-96/40751 (1996-12-01), None
patent: WO-96/40752 (1996-12-01), None
patent: WO-97/17364 (1997-05-01), None
patent: WO-97/22621 (1997-06-01), None
Bai, Ruoli et al., “Dolastatin 15, a potent antimitotic depsipeptide derived fromDolabella auricularia. Interaction with tubulin and effects on cellular microtubules,”Chemical Abstracts, vol. 117(11):41, 117:103735g (1992).
Bai, Ruoli et al., “Dolastatin 15, a Potent Antimitotic Depsipeptide Derived fromDolabella auricularia,” Biochemical Pharmacology, vol. 43(12):2637-2645 (1992).
Bai, Ruoli et al., “Structure-activity Studies with Chiral Isomers and with Segments of the Antimitotic Marine Peptide Dolastatin 10,”Biochemical Pharmacology, vol. 40(8):1859-1864 (1990).
Miyazaki, Koichi et al., “Synthesis and Antitumor Activity of Novel Dolastatin 10 Analogs,”Chem. Pharm. Bull., vol. 43(10):1706-1718 (1995).
Pettit, George R. et al., “Antineoplastic Agents. 220. Synthesis of Natural (−)-Dolastatin15,”J. Am. Chem., vol. 113:6692-6693 (1991).
Pettit, George R. et al., “Antineoplastic agents 337. Synthesis of dolastatin 10 structural modifications,”Anti-Cancer Drug Design, vol. 10:529-544 (1995).
Pettit, George R. et al., “Isolation and Structure of the Cytostatic Depsipeptide Dolastatin 13 from the Sea HareDolabella auricularia,”J. Am. Chem., vol. 111:5015-5017 (1989).
Pettit, George R. et al., “Isolation and Structure of the Cytostatic Linear Depsipsptide Dolastatin 15,”J. Am. Chem., vol. 54:6005-6006 (1989).
Pettit, George R. et al., “Isolation of Dolastatins 10-15 from the Marine MolluscDolabella auricularia,” Tetrahedron, vol. 49(41):9151-9170 (1993).
Pettit, George R. et al., “The Dolastatins 20. A Convenient Synthetic Route to Dolastatin 15,”Tetrahedron, vol. 50(42):12097-12108 (1994).
Pettit, George R. et al., “The Isolation and Structure of a Remarkable Marine Animal Antineoplastic Constituent: Dolastatin 10,”J. Am. Chem., vol. 109:6883-6885 (1987).

Affiliated with

Also associated with

Rating

Dolastatin 15 derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dolastatin 15 derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dolastatin 15 derivatives will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4172599